• ABA's Response to Recession• BioBlurb
• Clinical Trials and the Financial Markets
• E-Discovery and Digital Evidence Case Digest
• Free Cleantech Brown Bag
• How to Get a Job and Grow Your Practice
• ABA Member Advantage Benefits
• Proposed Patent Case Legislation
Learn about Section
member professional updates.
• Computer Forensic Resolution Has Impact in North Carolina
• Highlight Section Involvement
• Join ABA's Green Initiative
• Leverage The SciTech Lawyer Electronic Archives
• Nominees for Section Officers and Council Positions
• Resources for Student Members
• Student Opportunity at 2009 ABA Annual Meeting
• Update your ABA AOC
2nd National Conference on Employment of Lawyers with Disabilities
June 15-16, 2009
Marriott Wardman Park Hotel
2009 ABA Annual Meeting
July 29 - August 2, 2009
This book provides you with a legal and practical approach to the new world of digital information. It has been described as a must have for litigation lawyers, corporate counsel and records managers who want to understand how to appropriately handle the digital information of an enterprise. Learn more.
This book clearly explains and discusses 13 applied scientific disciplines in jargon-free language that is specifically geared toward lawyers. If you are a lawyer who is ever called upon to defend, proceed against, examine, cross-examine or even consult a scientist, this book is for you. Learn more.
The SciTech Lawyer
The Section’s quarterly magazine features practical and timely articles on a diverse range of science and technology law issues. This issue focuses on biosecurity.
In This Issue
bioblurb by Lisa M. von Biela
A MESSAGE FROM YOUR EDITOR:
We've got it all this week-everything including red, glow-in-the-dark beagle pups. I can see the advantage in that. Have the right UV light going, and you'll never trip on your dog in the dark again. Could save some broken bones.
CONTRIBUTOR CREDITS FOR THIS ISSUE:
Thanks to Becky Fe de Montreve-McMinn and Hugh Wellons for their contributions this week!
1. Hospitals replace DNR with "Allow Natural Death." OK, this is a little more Health Law than Biotech, but . . .
FortWayne.com, 4/27/09, via Becky.
2. Institute of Medicine calls on doctors to stop taking industry gifts. The chorus is growing . . .
BIOTECH AND THE LAW:
1. Wyeth decision opens the floodgates for failure to warn suits.
waiting in the wings now reanimated.
Bloomberg, 4/30/09, via FDLI SmartBrief.
2. McKesson drug price fraud settlement wins initial approval from court.
Bloomberg, 4/23/09, via FDLI SmartBrief.
BIOTECH IN CLINICAL MEDICINE:
1. Autism tied to older moms, breech birth.
Yahoo! News, 4/28/09, via Becky.
2. Gene alterations associated with response to anthracycline therapy for breast cancer.
EurekAlert!, 4/28/09, via CDC Weekly Newsletter.
3. Discovery of key genetic factors that drive the process of generating new heart cells.
News-Medical.net, 4/26/09, via CDC Weekly Newsletter.
1. Drug library helps in developing new remedies from old.
NY Times, 4/28/09, via Hugh.
2. Nanoparticles may help to attack cancer more directly. Bucky Balls, anyone?
Yahoo! News, 4/26/09, via Hugh.
3. Gene-laden bubbles grow new blood vessels.
Science Daily, 4/26/09, via CDC Weekly Newsletter.
COMMERCIAL BIOTECH APPLICATIONS:
1. Utah rolls out first U.S. open source disease tracker. Gee, just in time with this swine flu business going on . . .
Government Health IT, 4/23/09, via Becky.
2. Report recommends certain priorities when implementing electronic health records.
Health Data Management, 4/24/09, via Becky.
3. DTC genetic tests banned in Germany.
PHG Foundation, 4/28/09, via CDC Weekly Newsletter.
4. Microsoft aims to help scientists move past Excel, make sense of gene data overload. Wonder what name they'll come up with? Genome 2010? PowerDNAPoint? ChromasomeServer? Sorry, could not help myself!
1. Recession puts squeeze on hospital IT projects.
Healthcare IT News, 4/27/09, via Becky.
2. FDA approves J&J's rheumatoid arthritis drug golimumab-expected to be a blockbuster. I know, that looks like a major typo on my part, but it is not.
LA Times, 4/25/09, via FDLI SmartBrief.
LEGISLATIVE AND POLICY DEVELOPMENTS:
1. Republican senator pushes for biotech funding, new agency.
Reuters, 4/25/09, via Hugh.
2. Sebelius sworn in as HHS secretary.
3. Two senators introduce bill on FDA inspection of drug plants.
Bloomberg, 4/23/09, via FDLI SmartBrief.
1. Watson and Novartis battle over Enablex patent.
Forbes, 4/28/09, via FDLI SmartBrief.
2. Sanofi loses appeal on Lovenox patent. What is this? The meds all need to end in "x" this week!
Bloomberg, 4/27/09, via FDLI SmartBrief.
REGULATORY MATTERS/FDA ACTIVITY:
1. FDA allows uncleared uses of flu drugs and tests. Oxymoron of the week: authorized off-label use.
Reuters, 4/27/09, via Hugh.
2. "Pharma-scolds" scolded. I can see the fingers wagging now!
Forbes, 4/29/09, via FDLI SmartBrief.
3. Acetaminophen products to contain stronger warnings on labels in U.S.
Reuters, 4/29/09, via FDLI SmartBrief.
1. South Korean experts claim to have cloned glowing dogs. They look like normal beagles, but put them under UV light and they glow red. What *will* they think of next? Hot dog!
Yahoo! News, 4/28/09, via FDLI SmartBrief.
BioBlurb is a weekly member benefit of the Biotechnology Law Committee. Click here to join the Biotechnology Law Committee for free today!
Lisa M. von Biela
J.D. Candidate, 2009
University of Minnesota Law School
Your e-mail address will only be used within the ABA and its entities. We do not sell or rent e-mail addresses to anyone outside the ABA.
American Bar Association | 321 N Clark | Chicago, IL 60654 | 1-800-285-2221